$0.1050
0.0116.54%
At close: -
Comments
Loading...
Glucose Health Analyst Ratings and Price Targets | OTC:GLUC | Benzinga
Glucose Health Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Glucose Health Corp from these most-recent analyst ratings.
Analyst Ratings for Glucose Health
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Glucose Health (GLUC) stock?
There is no price target for Glucose Health
What is the most recent analyst rating for Glucose Health (GLUC)?
There is no analyst for Glucose Health
When was the last upgrade for Glucose Health (GLUC)?
There is no last upgrade for Glucose Health
When was the last downgrade for Glucose Health (GLUC)?
There is no last downgrade for Glucose Health.
When is the next analyst rating going to be posted or updated for Glucose Health (GLUC)?
There is no next analyst rating for Glucose Health.
Is the Analyst Rating Glucose Health (GLUC) correct?
There is no next analyst rating for Glucose Health.
Browse analyst ratings and price targets on all stocks.